Supplementary Information

Synthesis of HA-THP
To prepare HA-THP conjugate, the desalted HA (100 mg) was dissolved in 2 mL of anhydrous DMSO under nitrogen. Subsequently, EDC (96 mg) and NHS (58 mg) dissolved in anhydrous DMSO (1 mL), were slowly added to the HA solution. The mixture was stirred for 1 h at room temperature to activate the HA carboxylic group. After 1 h, THP-amine (5 mg) and TEA (70 μL) were added to the activated HA solution. Subsequently, the solution was allowed to react for 24 h at room temperature. The product was subsequently purified by successive dialysis for 4 days, changing media two times per day (MWCO 10 Da) against excess of 0.1 M NaCl, 25 % (v/v) ethanol solution and then deionized water at RT. The solution was then lyophilized and stored at -20 °C until further use. The amount of THP-amine in the conjugate was determined using a calibration curve of THP-amine measured at 288 nm ( Figure 3C ). The calibration curve was prepared by dissolving known concentrations (2, 4, 8, 12 , 20 μg/mL) of THP-amine in PBS (pH 7.4) ( Figure 3D ).
Synthesis of HA-4'-AMF
To prepare HA-4'AMF conjugate, the desalted HA (100 mg) was dissolved in 2 mL of anhydrous DMSO under nitrogen. Subsequently, EDC (96 mg) and NHS (58 mg) dissolved in anhydrous DMSO (1 mL), were slowly added to the HA solution. The mixture was stirred for 1 h at room temperature to activate the HA carboxylic group. After 1 h, 4'-AMF (5 mg) and TEA (70 μL) were added to the activated HA solution. Subsequently, the solution was allowed to react for 24 h at room temperature. the produc was purified by successive dialysis for 4 days, changing media two times in a day (MWCO 10 kDa) against excess of 0.1 M NaCl, 25 % (v/v) ethanol solution and then deionized water at room RT. The solution was then lyophilized and stored at -20 °C in the dark until further use. The amount of HA-4'-AMF in the conjugate was determined using a calibration curve of 4'-AMF prepared at emission spectrum of 515 nm when keeping excitation wavelength at 480 nm ( Figure 3E ). The calibration curve was prepared by dissolving different concentration (0.5, 1, 2, 3, 4 μg/mL) of 4'-AMF in PBS (pH 10) ( Figure 3F ). Figure S1 : RP-HPLC quantification of Gem. (A) Calibration curve and (B) retention time of Gem in HPLC quantification. The experiment was done using RP-HPLC (SHIMADZU prominence, Japan), C-18 column (C-18G 250 x 4.5 mm) operated at 30˚C with PDA detector (SPD-M20A) at a wavelength of 266 nm. The mobile phase consisted of acetonitrile/water (70:30, v/v) with a flow rate of 1 mL/min. The retention time at 6.8 min was considered as Gem and the concentrations were calculated from Gem calibration curve prepared under the identical condition. The effect of nucleoside transporter inhibition, using dipyridamol, on Gem or HA-Gem cytotoxicity, was studied with MTT assay, in CT26 and PANC-1 cells. Cells were pre-incubated with dipyridamol (10 µM) for 30 min, prior co-incubation with different concentration (0.01 to 100 μM) of Gem or HA-Gem for 24 h. Percentage viability was assessed with MTT assay and calculated as a percentage of untreated cells and expressed as mean ± SD ( n = 5). * P < 0.05, ** P < 0.01, *** P < 0.001 Gem versus HA-Gem. 6 CT26 cells. The animals were then divided randomly into four groups: Untreated (control), 10 mg/kg Gem (free drug), 40 mg/kg Gem and 120 mg/kg Gem. Mice were administered a total of 4 injections intravenously on day 7, 10, 14 and 18 post-tumor inoculation at a drug dose of 10, 40 and 120 mg/kg of Gem. The size of the tumor was measured three times in a week. Data are presented as mean value ± SD (n = 9). The statics were applied using one-way ANOVA following Bonferroni post comparison test. *p< 0.05, *** P < 0.001. 6 CT26 cells. The animals were then divided randomly into five groups: Untreated (control), 15 mg/kg Gem (free drug), 30 mg/kg Gem, 15 mg/kg HA-Gem and 30 mg/kg HA-Gem. Mice were intravenously administered a total of 4 injections on day 7, 10, 14 and 18 post-tumor inoculation with the particular treatment. The body weight of the animal was measured three times in a week. Data are given as mean value ± SD (n = 8).
Supplementary Figures
Figure S8: Histology examination of major organs in CT26 tumor-bearing BALB/c mice after treatment of Gem or HA-Gem. Mice transplanted subcutaneously with CT26 cells were divided randomly into five groups: Untreated (control), 15 mg/kg Gem (free drug), 30 mg/kg Gem, 15 mg/kg HA-Gem and 30 mg/kg HA-Gem. Mice were intravenously administered a total of 4 injections on day 7, 10, 14 and 18 post-tumor inoculation with the particular treatment. Major organs including heart, lung, liver, spleen and kidney are excised at the experimental end point of each group, and the tissue sections were preceded for H&E staining. No obvious histological changes were observed in these organs after treatments compared to the untreated group. Scale bar: 100 μm.
